Vaccination in Individuals with Multiple Sclerosis – Part I

Bilge Piri Çınar1, Aslı Tuncer2, Nuray Bilge3, Sena Destan Bünül4, Rabia Gökçen Gözübatık-çelik5, Eda Derle Çiftçi6, Gencer Genç7, Bedriye Karaman8, Ahmet Kasım Kılıç9, Alp Sarıteke10, Meral Seferoğlu11, Bedile İrem Tiftikçioğlu12, Abdulkadir Tunç13, Gülgün Uncu14, İrfan Yavaş15, Mehmet Fatih Yetkin16, Hüsnü Efendi4, Aksel Siva17

1Samsun University Faculty of Medicine, Department of Neurology, Samsun, Türkiye
2Hacettepe University Faculty of Medicine, Department of Neurology, Ankara, Türkiye
3Ataturk University Faculty of Medicine, Department of Neurology, Erzurum, Türkiye
4Kocaeli University Faculty of Medicine, Department of Neurology, Kocaeli, Türkiye
5University of Health Sciences Türkiye, Istanbul Bakirkoy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
6Baskent University Faculty of Medicine, Department of Neurology, Ankara, Türkiye
7University of Health Sciences Türkiye, Sisli Hamidiye Etfal Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
8Ege University Faculty of Medicine, Department of Neurology, Izmir, Türkiye
9Kartal Dr. Lutfi Kirdar Training and Research Hospital, Clinic of Neurology, Istanbul, Türkiye
10University of Health Sciences Türkiye, Izmir Tepecik Training and Research Hospital, Clinic of Neurology, Izmir, Türkiye
11Bursa Yüksek İhtisas Training and Research Hospital, Clinic of Neurology, Bursa, Türkiye
12Bakircay University Training and Research Hospital, Clinic of Neurology, Izmir, Türkiye
13Sakarya University Training and Research Hospital, Clinic of Neurology, Sakarya, Türkiye
14Eskisehir City Hospital, Clinic of Neurology, Eskisehir, Türkiye
15Karabuk University Faculty of Medicine, Department of Neurology, Karabuk, Türkiye
16Erciyes University Faculty of Medicine, Department of Neurology, Kayseri, Türkiye
17Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Neurology, Istanbul, Türkiye

Keywords: Multiple sclerosis, vaccination, safety

Abstract

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections.

Peer Review

Externally peer-reviewed.

Author Contributions

Concept: B.P.Ç., A.T., Al.S., H.E., Design: B.P.Ç., A.T., Data Collection or Processing: All authors, Analysis or Interpretation: B.P.Ç., A.T., Ak.S., H.E., Literature Search: All authors, Writing: B.P.Ç., A.T.

Conflict of Interest

No conflict of interest was declared by the authors.

Financial Disclosure

The authors declared that this study received no financial support.